Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test

References

• WHO. Novel coronavirus – China. [cited 2020 Jan 19] Available from: http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ .
   Google Scholar
• World Health Organization (WHO). Outbreak Investigation. [cited 2020 Mar 13] Available from: https://www.who.int/hac/techguidance/training/outbreak%20investigation_en.pdf.
   Google Scholar
• Carenzo L, Costantini E, Greco M, et al. Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia. 2020. doi:10.1111/anae.15072.
   PubMed Web of Science ®Google Scholar
• WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-oncovid-19-final-report.pdf (2020).
   Google Scholar
• Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) (July 3rd, 2020). Available from: https://coronavirus.jhu.edu/map.html.
   Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. doi:10.1056/NEJMoa2002032
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020. doi:10.1001/jama.2020.5394.
   Web of Science ®Google Scholar
• Patrick K, Stanbrook MB, Laupacis A. Soci al distancing to combat COVID-19: We are all on the front line. CMAJ. 2020. doi:10.1503/cmaj.200606.
   Web of Science ®Google Scholar
• Tang YW, Schmitz JE, Persing DH, et al. The laboratory diagnosis of COVID-19 infection: current issues and challenges. J Clin Microbiol. 2020; pii: JCM.00512-20. doi:10.1128/JCM.00512-20.
   Web of Science ®Google Scholar
• Jia Z, Lu Z. Modelling COVID-19 transmission: from data to intervention. Lancet Infect Dis. 2020; pii: S1473-3099(20)30258-9. doi:10.1016/S1473-3099(20)30258-9.
   PubMed Web of Science ®Google Scholar
• Nishiura H, Jung SM, Linton NM, et al. The Extent of transmission of Novel coronavirus in Wuhan, China, 2020. J Clin Med. 2020;9(2). pii: E330. doi:10.3390/jcm9020330.
   Web of Science ®Google Scholar
• Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020; pii: eabb3221. doi:10.1126/science.abb3221.
   Web of Science ®Google Scholar
• WHO. Diagnostic detection of 2019-nCoV by real-time RT-PCR. Available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2; accessed Apr 8, 2020.
   Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:2000045.
   Web of Science ®Google Scholar
• Chang, Mo G, Yuan X, et al. Time Kinetics of viral clearance and Resolution of symptoms in Novel coronavirus infection. Am J Respir Crit Care Med. 2020. doi:10.1164/rccm.202003-0524LE.
   Web of Science ®Google Scholar
• Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9:386–389.
   PubMed Web of Science ®Google Scholar
• Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in Different Types of clinical specimens. JAMA. 2020. doi:10.1001/jama.2020.3786.
   Web of Science ®Google Scholar
• Rubin GD, Ryerson CJ, Haramati LB, et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the fleischner aociety. Radiology. 2020;7:201365), doi:10.1148/radiol.2020201365.
   Web of Science ®Google Scholar
• Lai CC, Liu YH, Wang CY, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020; pii: S1684-1182(20)30040-2. doi:10.1016/j.jmii.2020.02.012.
   Google Scholar
• Tan W, Lu Y, Zhang J, et al. Viral Kinetics and antibody responses in patients with COVID-19. MedRxiv. doi:10.1101/2020.03.24.20042382.
   Google Scholar
• Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. doi:10.1038/s41586-020-2196-x.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020; pii: ciaa344. doi:10.1093/cid/ciaa344.
   Web of Science ®Google Scholar
• Channappanavar R, Zhao J, Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol Res. 2014;59:118–128.
   PubMed Web of Science ®Google Scholar
• Jin Y, Wang M, Zuo Z, et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int J Infect Dis. 2020; pii:S1201-9712(20)30198-3. doi:10.1016/j.ijid.2020.03.065.
   Web of Science ®Google Scholar
• Lassaunière R, Frische A, Harboe ZB et al. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv Preprint doi:10.1101/2020.04.09.20056325.
   Google Scholar
• FIND evaluation update: SARS-CoV-2 immunoassays: [cited 2020 Jul 3] Available from: https://www.finddx.org/covid-19/pipeline/?avance=all&type=Rapid+diagnostic+tests&test_target=Antibody&status=all&section=immunoassays&action=default#diag_tab.
   Google Scholar
• Website for statistical Computation on [cited 2020 Apr 12] Available from: http://vassarstats.net/.
   Google Scholar
• Hope MD, Raptis CA, Shah A, et al. A role for CT in COVID-19? what data really tell us so far. Lancet. 2020; pii: S0140-6736(20)30728-5. doi:10.1016/S0140-6736(20)30728-5.
   PubMed Web of Science ®Google Scholar
• Woo PC, Lau SK, Wong BH, et al. Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory Syndrome (SARS) coronavirus Nucleocapsid protein in patients with pneumonia Due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004;11:665–668.
   PubMedGoogle Scholar
• Mo H, Zeng G, Ren X, et al. Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology. 2006;11:49–53.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wan Z, Li L, et al. Antibody responses against SARS-coronavirus and its nucleocapsid in SARS patients. J Clin Virol. 2004;31:66–68.
   PubMed Web of Science ®Google Scholar
• Lin Q, Zhu L, Ni Z, et al. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection. J Microbiol Immunol Infect. 2020; pii: S1684-1182(20)30075-X. doi:10.1016/j.jmii.2020.03.015.
   Google Scholar
• Bendavid E, Mulaney B, Sood N, et al. COVID-19 Antibody Seroprevalence in Santa Clara County, California. medRxiv preprint doi:10.1101/2020.04.14.20062463.
   Google Scholar